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Abstract: 15 compounds, including two new ones crepidatuols A (1) and B (2) were isolated from the stems of Dendrobium  
crepidatum. The planar structures of these compounds were elucidated by spectroscopic methods (NMR, MS, UV, and IR) and 
comparison with those from literatures. 10 compounds were send for enhancing activities on nerve growth factor (NGF) medicated 
neurite outgrowth in PC12 cells and the results indicated that crepidatuol A (1), confusarin and 3-(2-acetoxy-5-methoxy)-
phenylpropanol showed enhancing activities at the concentration of 10.0 µM. 
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Introduction 
The stems of several Dendrobium species (Orchidaceae) are 
used as "Shi-Hu" in traditional Chinese medicine for a long 
time for the purpose of being beneficial to the stomach and 
promoting the production of body fluid, nourishing yin and 
clearing heat.1,2 Inspired by this theory, "Shi-Hu" is mainly 
used for thrombotic diseases and health care especially for 
those older. D. crepidatum belongs to Sect. Dendrobium and 
the stems of this species used as a biological source of "Shi-
Hu" and its flowers are very beautiful and get the name "Rosa 
Shi-Hu" in Chinese.3 Alkaloidal part of this species has been 
detected by Elander etc. and five octahydroindolizine alkaloids 
have been isolated and elucidated.4 To continue our research 
on "Shi-Hu"5 and provide chemical evidence for this traditional
Chinese medicine, D. crepidatum was selected as our plant 
material and 15 compounds, including two new compounds, 
crepidatuols A (1) and B (2) (Figure 1) were isolated and  
elucidated herein, furthermore, 10 compounds were sent to 
assay their neurite outgrowth enhancing activities and the  
results indicated that three of them showed neuroprotective 
effects. 
 
Results and Discussion 
Compound 1 was obtained as yellow oil. Its molecular 
formula was established as C26H28O6 by the HREIMS showing 
a molecular ion peak at m/z 436.1882 (calcd. for C26H28O6 
436.1886), indicating thirteen degrees of unsaturation. The UV 
spectra at λmax (log ε): 282.5 (3.9) nm indicated an extended 
conjugated system. The 1H and 13C NMR spectra data of 1 
(Table 1) showed the existence of three methoxy groups, four 
aliphatic methylenes, one aliphatic methine and three aromatic 
rings. Two methylene carbons at δC 36.2 (C-7) and 35.0 (C-8) 
correlated with four benzylic protons at δH 2.82 (4H, m, H-7 
and H-8) in the HSQC spectrum of 1 indicated a bibenzyl 
nucleus,6 which was confirmed by the correlations [H-7, H-
8/C-1, C-2, C-6, C-9, C-10, C-14] in the HMBC spectrum 
(Figure 2). Three aromatic hydrogen at δH 6.63 (1H, d, 1.8), 
6.85 (1H, d, 8.1) and 6.71 (1H, dd, 8.1, 1.8) indicated a 1,3,4-
trisubstituted phenyl, moreover, two others at δH 6.42 (1H, d, 
2.5) and 6.39 (1H, d, 2.5) showed another phenyl with two 
meta-coupling hydrogen for the bibenzyl nucleus. The 
correlations [H-16/H-15, H-17] in the COSY spectrum 
indicated a structural moiety of -CH2-CH2-CH- (C-15, C-16, 
C-17), furthermore, the correlations [H-15/C-14 and C-13, H-
 
Figure 1.  Structures of compounds 1 and 2 
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16/C-14 and C-18, H-17/C-18, C-19 and C-23] in the HMBC 
spectrum indicated that the partial structure and the related 
aromatic ring were linked with the bibenzyl nucleus as 
trigonopol B5a except hydride reduction at C-16. Three 
methoxy groups could be observed that δH 3.92 (3H, s) 
belongs to δC 55.9, δH 3.76 (3H, s) belongs to δC 55.2, δH 3.86 
(3H, s) belongs to δC 55.8 in the HSQC spectrum respectively, 
furthermore, cross peaks of  
δH 3.92 (3H, s) with δC 146.6, δH 3.86 (3H, s) with δC 146.2,  δH 3.76 (3H, s) with δC 158.6 in the HMBC spectrum 
determined the position of three methoxy groups as shown  
in Figure 1. Thus, compound 1 was identified as 4-(5- 
(4-hydroxy-3-methoxyphenethyl)-7-methoxychroman-2-yl)-2-
methoxyphenol, named as crepidatuol A. 
Compound 2 was obtained as yellow oil, its molecular 
formula was determined as C26H28O7 by the HRESIMS (m/z 
452.1832 [M]+, calcd. for 452.1835), with thirteen degrees of 
unsaturation. The 13C NMR and DEPT spectrum exhibited 26 
carbon signals, including three methoxy, three aliphatic 
methylenes, two aliphatic methines and three aromatic rings. 
The 1H and 13C NMR data of 2 (Table 1) were similar to those 
of trigonopol B5a as compound 1, indicating a similar bibenzyl 
core for compound 2. The threo-isomer (6–8 Hz) is larger than 
in the erythro-isomer (2–4 Hz)5e, from the chemical shifts  
and the coupling constants (J = 8.7) of compound 2 and 
trigonopol B (J = 6.4), it could be predicated that relative 
stereochemistry of C-16 and C-17 were similar in two 
compounds. One more methoxy in 2 than trigonopol B  
and correlations [H-24/C-3, H-25/C-11, H-26/C-20] in the 
HMBC spectrum (Figure 2) indicated that compound 2 was  
5-(4-hydroxy-3-methoxyphenethyl)-2-(4-hydroxy-3-methoxy-
phenyl)-7-methoxychroman-3-ol as shown in figure 1, named 
as crepidatuol B. 
The 13 known compounds were elucidated as  
erianin,7 crepidatin,8 moscatilin,8 hircinol,9 confusarin,10 
syringaldazine,11 3-(2-acetoxy-5-methoxy)phenylpropanol,11 
kaempferol,12 4,6-dihydroxyisobenzofuran-1(3H)-one,13 
ergostan-7,9,22-trien-3,5-diol,14 ergosterol,15 β-sitosterol and 
daucosterol by comparing with those from literature and TLC 
means. 
For the purpose of evaluating the effect of neuroprotective 
effects of this species, the isolated 10 compounds including 
crepidatuol A (1), erianin, crepidatin, moscatilin, confusarin, 
3-(2-acetoxy-5-methoxy)-phenylpropanol, kaempferol, 4,6-
dihydroxyisobenzofuran-1(3H)-one, ergostan-7,9,22-trien-3,5-
diol and ergosterol were evaluated for their enhancing activity 
on NGF-induced (nerve growth factor, R&D Systems Inc., 
97%) neurite outgrowth in PC12 cells.16 The results  
indicated that the proportion of the NGF-induced (10 ng/mL) 
neurite-bearing cells were enhanced by crepidatuol A (1, 
8.5%), confusarin (7.1%) and 3-(2-acetoxy-5-methoxy)-
phenylpropanol (6.8%) at the concentration of 10 µM (Table 
2). Others showed no activity on 10 ng/mL NGF-induced  
neurite outgrowth in PC12 cells at 10.0 µM. 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 




δH δC δH δC 
1  133.6, s  133.4, s 
2 6.63 (1H, d, 1.8) 111.1, d 6.64 (1H, d, 1.8) 110.9, d 
3  146.6, s 146.2, s
4  143.8, s  143.8, s  
5 6.85 (1H, d, 8.1) 114.2, d 6.84 (1H, d, 7.9) 114.2, d 
6 6.71 (1H, dd, 8.1, 1.8) 120.9, d 6.70 (1H, dd, 7.9, 1.8) 120.9, d 
7 2.82 (2H, m) 36.2, t 2.81 (2H, m) 36.2, t 
8 2.82 (2H, m) 35.0, t 2.81 (2H, m) 35.1, t 
9  141.7, s  142.2, s 
10 6.42 (1H, d, 2.5) 108.2, d 6.45 (1H, d, 2.1) 108.9, d 
11  158.6, s  158.9, s 
12 6.39 (1H, d, 2.5) 99.5, d 6.39 (1H, d, 2.1) 99.1, d 
13  156.1, s  155.1, s 
14  112.3, s  110.8, s 
15 2.69 (2H, m) 22.1, t 2.63 (1H, dd, 15.6, 9.1, Ha); 3.03 (1H, dd, 15.6, 5.8, Hb) 30.3, t 
16 2.03 (1H, m, Ha); 2.19 (1H, m, Hb) 30.1, t 4.02 (1H, ddd, 9.1, 8.7, 5.8) 68.6, d 
17 4.89 (1H, d, 10.5, 1.8) 77.5, d 4.59 (1H, d, 8.7) 81.6, d 
18  133.6, s  129.4, s 
19 6.97 (1H, s) 108.6, d 6.97 (1H, d, overlapped) 109.3, d 
20  146.2, s  146.9, s 
21  145.4, s  146.1, s  
22 6.93 (1H, overlapped) 114.2, d 6.97 (1H, d, overlapped)  114.5, d 
23 6.92 (1H, overlapped) 119.2, d 6.97 (1H, d, overlapped) 120.6, d 
24 3.92 (3H, s) 55.9, q 3.87 (3H, s) 55.8, q
25 3.76 (3H, s) 55.2, q 3.75 (3H, s) 55.2, q 
26 3.86 (3H, s) 55.8, q 3.92 (3H, s) 55.9, q 
 
Figure 2.  Selected 1H-1H COSY and HMBC correlations of 
compounds 1 and 2 
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measured using a JASCODIP-370 polarimeter. UV spectra 
were obtained with a Hitachi UV-3210. IR spectra were  
recorded on a Bio-Rad BRUKER TENSOR27 IR  
spectrophotometer as KBr disks. NMR spectra were run on 
Bruker AVANCE 400 NMR spectrometer (400 MHz for 1H 
NMR, 100 MHz for 13C NMR) and DRX-500 NMR spectrom-
eter (500 MHz for 1H NMR, 125 MHz for 13C NMR) with 
TMS as internal standard. Mass spectra were performed on a 
AutoSpec Premier P776 mass spectrometer. Column chroma-
tography was carried out on silica gel H60 (Qingdao Haiyang 
Chemical Group Corp., Qingdao, China), Sephadex LH-20 
(Amersham Biosciences), and ODS (40–63 μm, Merck) as 
packing materials. Silica gel G was used for analytical TLC. 
 
Plant Material. The fresh stems of D. crepidatum were  
collected in Yunnan Province in 2008 and identified by  
Professor Hong Yu of Yunnan University. A voucher specimen
(Zsh-8) was deposited at the State Key Laboratory of  
Phytochemistry and Plant Resources in West China, Kunming 
Institute of Botany, Chinese Academy of Science, China. 
 
Extraction and Isolation. The air-dried stems of D.  
crepidatum (15 kg) were refluxed three times with 95% EtOH. 
After evaporation of solvent in vacuo, the residue was  
suspended in H2O and adjusted pH to 2 with hydrochloric acid. 
Then partitioned with chloroform and non-alkaloid fraction 
(1000 g) were obtained. Then the non-alkaloid fraction was 
subjected to column chromatography on silica gel (200–300 
mesh, 6 kg) and eluted with petroleum ether/acetone 
(6:4→0:10) to afford 7 fractions. Fraction B (120g) was  
applied repeatedly to column chromatography over silica gel 
(petroleum ether/acetone, 10:1 to 1:1) and got 13 (267 mg), 14 
(259 mg) and 16 (1.1 g), then residue were purified with  
Sephadex LH-20 (CHCl3-MeOH, 1:1) to afford compounds 1 
(29 mg), 4 (1.73 g), 9 (9 mg) and 10 (11 mg). Fraction C (62.7 
g) was chromatographed on silica gel (petroleum ether-acetone, 
5:1 to 1:1) to afford 7 fractions. Each fraction was subjected 
repeatedly to column chromatography over silica gel and then 
passed over Sephadex LH-20 (MeOH) respectively to afford 
compounds 5 (43 mg), 7 (11 mg) and 12 (17 mg). Fraction D 
was treated the same as Fraction C to afford compounds 6 (28 
mg), 8 (14 mg) and 11 (300 mg). Fraction E was subjected to 
column chromatography over silica gel and got 15 (400 mg) 
and then applied to ODS column (MeOH-H2O, 3:7→5:5) and 
Sephadex LH-20 column (MeOH) to yield compounds 2 (5 mg) 
and 3 (4 mg). 
Crepidatuol A (1): yellow oil, [α] 16.8D   – 11.89 (c 0.15, 
CHCl3), UV (CHCl3): λmax (log ε) 282.5 (3.9) nm; IR (KBr): νmax 3431, 2924, 2850, 1614, 1583, 1516, 1463, 1428, 1364, 
1270, 1196, 1140, 1032 cm–1; 1H NMR (CDCl3, 500 MHz) and 
13C NMR (CDCl3, 125 MHz) data: see Table 1; EIMS m/z 436 
(92), 299 (28), 285 (46), 137 (100); HREIMS m/z 436.1882 
[M]+ (calcd for C26H28O6, 436.1886). 
 
Crepidatuol B (2): yellow oil, [α] 11.9D   + 0.24 (c 0.26, 
CHCl3), UV (CHCl3): λmax (log ε) 282.0 (3.87) nm; IR (KBr): νmax 3493, 3313, 2923, 2852, 1728, 1614, 1584, 1516, 1463, 
1272, 1197, 1140, 1031 cm–1; 1H NMR (CDCl3, 500 MHz) and 
13C NMR (CDCl3, 125 MHz) data: see Table 1; EIMS m/z 452 
(37), 287 (63), 137 (100); HREIMS m/z 452.1832 [M]+ (calcd 
for C26H28O7, 452.1835). 
 
Cell Culture and Evaluation of Neurite Outgrowth-
Promoting Activity. The neurotrophic activities of the test 
compounds were examined according to an assay using PC12 
cells as reported.17 Briefly, PC12 cells were maintained in F12 
medium supplemented with 12.5% horse serum (HS), and 
2.5% fetal bovine serum (FBS), and incubated at 5% CO2 and 
37 °C. Test compounds were dissolved in DMSO. For the 
neurite outgrowth-promoting activity bioassay, PC12 cells 
were seeded at a density of 2 × 104 cells/mL in 48-well plate 
coated with poly-L-lysine. After 24 h, the medium was 
changed to that containing 10 µM of each test compounds plus 
10 ng/mL nerve growth factor (NGF), or various concentra-
tions of NGF (50 ng/mL for the positive control, 10 ng/mL for 
the negative control). The final concentration of DMSO was 
0.1%, and the same concentration of DMSO was added into 
the negative control and blank. After 72 h incubation, the  
neurite outgrowth was assessed under a phasecontrast micro-
scope. Neurite processes with a length equal to or greater than 
the diameter of the neuron cell body were scored as neurite 
bearing cells. The ratio of the neurite-bearing cells to total 
cells (with at least 100 cells examined/view area; 5 viewing 
area/well) was determined and expressed as a percentage. 
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Table 2. The percentages of the neurite-bearing cells after 72 h 
incubation with compounds crepidatuol A, confusarin and 3-
(2-acetoxy-5-methoxy)-phenylpropanol 
group drug results (%) 
1 blank – 
2 Negative control 4.7  
3 Positive control 11.9  
4 crepidatuol A 8.5  
5 confusarin 7.1  
6 3-(2-acetoxy-5-methoxy)-phenylpropanol 6.8  
50 ng/mL of NGF was used as positive control and 10 ng/mL of 
NGF was used as negative control, concentration of three  
compounds was at 10 µM. 
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